Dry powder inhalers

Respiratory Care

Volumn 44, Issue 8, 1999, Pages 940-951

  Dhand, Rajiv ^a,b   Fink, James ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

Aerosol; Dry powder inhaler; Inhalation device; Inhaled medication; Metered dose inhaler; Micronized powder

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; FLUTICASONE PROPIONATE; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE;

AEROSOL; ASTHMA; BREATH HOLDING; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; HUMAN; HUMIDITY; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; POWDER INHALER; REVIEW;

EID: 0032795597     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Ganderton D. The generation of respirable clouds from coarse powder aggregates. J Biopharm Sci 1992;3:101-105.
2. Dolovich M, Rheim R, Rashid F, Coates G, Hill M, Bowen B. Measurement of the particle size and dosing characteristics of a radiolabelled albuterol-sulphate lactose blend used in the SPIROS dry powder inhaler. In Dalby RN, Byron P, Farr SY, editors. Respiratory drug delivery V. Buffalo Grove Interpharm Press; 1996. 332-335.
3. Hansen OR, Pederson S. Optimal inhalation technique with terbutaline Turbuhaler. Eur Respir J 1989;2(7) 637-639
4. Engel T, Heinig JH, Madsen F, Nikander K. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry powder inhaler device (Turbuhaler). Eur Respir J 1990;3(9):1037-1041
5. Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler Arch Dis Child 1990;65(3): 308-310.
6. Thorsson L, Edshacker S, Conradson TB. Lung deposition from Turbuhaler is twice that from a pressurized metered-dose inhaler pMDI. Eur Respir J 1994;7(10):1839-1844.
7. Svartengren K, Lindestad P, Svartengren M, Philipson K, Bylin G, Camner P Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics. Am J Respir Crit Care Med 1995,152(1).32-37.
8. Persson G, Wiren JE, The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler). Eur Respir J 1989,2(3):253-256.
9. Hill LS, Slater AL. A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med 1998;92(1):105-110.
10. Rajkumari NJ, Byron PR, Dalby RN. Testing of dry powder aerosol formulations in different environmental conditions. Int J Pharmac 1995;113:123-130.
11. Timsina MP, Martin GP, Van der Kolk H, Tushulzen E, Enthoben R. The effect of inhalation flow on the performance of a dry powder inhalation system. Int J Pharm 1992;81:199-203.
12. Timsina MP, Martin GP, Marriott C, Ganderton D, Yainneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994;101:1-13.
13. Hindle M, Byron PR. Dose emissions from marketed dry powder inhalers. Int J Pharmac 1995;116:169-177.
14. Kim CS, Garcia L. Delivery characteristics of albuterol powder aerosol by rotahaler. J Aerosol Med 1993;6:199-211.
15. Bisgaard H, Ifversen M, Klug B, Stamstrup K, Sumby B. Inspiratory flow rate through the Diskus/Accuhaler inhaler and Turbuhaler inhaler in children with asthma. J Aerosol Med 1995;8:100.
16. Pedersen S Delivery systems in children. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, editors. Asthma. Philadelphia: Lippincott-Raven: 1997:1915-1929.
17. Svedmyr N, Lofdahl C, Svedmyr K. The effect of powder aerosol compared to pressurised aerosol. Eur J Respir Dis 1982;63(suppl 119):81-88.
18. Fuller R. The Diskus: a new multi-dose powder device-efficacy and comparison with Turbuhaler. J Aerosol Med 1995;8(Suppl 2):S11-S17.
19. Olsson B, Asking L, Borgstrom L, Bondesson E. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. In: Dalby RN, Byron PR, Farr SY, editors Respiratory drug delivery V Buffalo Grove IL: Interpharm Press Inc; 1996:273-281.
20. Zainudin BM, Biddiscombe M, Tolfree SE, Short M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax 1990;45(6):469-173.
21. Borgstrom L, Newman SP. Total and regional lung deposition of Lerbutaline sulphate inhaled via a pressurised pMDI or via Turbuhaler. Int J Pharm 1993;97:47-53
22. Glaxo Wellcome Inc Diskhaler product information sheet. Glaxo Wellcome Inc. Research Triangle Park, North Carolina.
23. Tukainen H, Terho EO. Comparison of inhaled salbutamol powder and aerosol in asthmatic patients with low peak expiratory flow level. Eur J Clin Pharmacol 1985;27(6).645-647.
24. Golish J, Curtis-McCarthy P, McCarthy K, Kavuru M, Wagner W, Beck G, Eng P Albuterol delivered by metered-dose inhaler (pMDI). pMDI with spacer, and Rotahaler device: a comparison of efficacy and safety. J Asthma 1998;35(4):373-379.
25. Borgstrom L, Derom E, Stahl E, Wahlin-Boll E, Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 1996;153(5).1636-1640.
26. Newman SP, Pavia D, Clarke SW Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med 1980;73(11).776-779.
27. Lofdahl CG, Andersson L, Bondesson E, Carlsson LG, Friberg K, Hedner J, et al. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. Eur Respir J 1997;10(11):2474-2478.
28. Boulet LP, Cowie R, Johnston P, Krakovsky D, Mark S. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group. J Asthma 1995;32(6):429-436.
29. Pauwels RA, Hargreave FE, Camus P, Bukoski M, Stahl E. A 1-year comparison of Turbuhaler vs pressurized metered-dose inhaler in asthmatic patients. Chest 1996;110(1):53-57.
30. Selroos O, Backman R, Forsen KO, Lofroos AB, Niemisto M, Pietinalho A, et al. Local side effects during 4-year treatment with inhaled corticosteroids: a comparison between pressurized metereddose inhalers and Turbuhaler. Allergy 1994;49(10):888-890.
31. Willey RF, Milne LJ, Crompton GK, Grant IW. Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest 1976;70(1):32-38.
32. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a worksohp held in Eze, France, October 1992. Am Rev Respir Dis 1993;148(4 Pt 2): S1-S26.
33. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984;129(5):723-729.
34. Williamson I, Matusiewicz S. Brown PH, Greening AP, Crompton GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995;8(4): 590-592.
35. Toogood JH, Jennings B, Baskerville J, Andersson J, Johansson SA. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis 1984;65(1):35-44.
36. Virchow JC Jr, Kroegel C, Matthys H. Antiasthma drug delivery. What is on the horizon? (review) Clin Pharmacokinet 1994;27(2): 85-93.
37. Kesten S, Elias M, Cartier A, Chapman KR. Patient handling of a multidose dry powder inhalation device for albuterol. Chest 1994; 105(4) 1077-1081.
38. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994,105(1):111-116.
39. van der Palen J, Klein JJ, Schildkamp AM. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998;35(2):147-152.
40. Tonnesen F, Laursen LC, Evald T, Stahl E, Ibsen TB. Bronchodilating effect of terbutaline powder in acute severe bronchial obstruction Chest 1994;105(3):697-700.
41. Pauwels R, Inhalation device, pulmonary deposition and clinical effects of inhaled therapy (review). J Aerosol Med 1997;10(Suppl 1) S17-S21
42. Nana A, Youngchaiyud P, Maranetra N, Boe J, Lofdahl CG, Selroos O, Stahl E. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma. Respir Med 1998,92(2):167-172.
43. Hartley JP, Nogrady SG, Seaton A. Long-term comparison of salbutamol powder aerosol in asthmatic out-patients. Br J Dis Chest 1979;73(3).271-276
44. Muittari A, Ahonen A. Comparison of the bronchodilator effect of inhaled salbutamol powder and pressurized salbutamol aerosol. Curr Ther Res 1979;25 804-808.
45. Bronsky E, Bucholtsz GA, Busse WW, Chervinsky P, Condemi J, Ghafouri MA, et al. Comparison ot inhaled albuterol powder and aerosol in asthma. J Allergy Clin Immunol 1987;79(5).741-747.
46. Lundback B, Alexander M, Day J, et al Evaluation of fluticasone propionate (500 microg/day) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 mterog/day) administered by pressurized inhaler. Respir Med 1993,87(8):609-620.
47. Engel T, Heinig JH, Mailing HJ, Scharling B, Nikander K, Madsen F. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler Allergy 1989;44(3): 220-225.
48. Nieminen MM, Lahdensuo A. Inhalation treatment with budesonide in asthma: a comparison of Turbuhaler and metered dose inhalation with Nebuhaler. Acta Therapeutica 1945;21:179-192.
49. Togood JH, White FA, Baskerville JC, Fraher LJ, Jennings B. Comparison of the antiasthmatic, oropharngeal, ard systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. J Allergy Clin Immunol 1997;99(2):186-193.
50. Dalby RN, Hickey AJ, Tiano SL, Medical devices for the delivery of therapeutic aerosols to the lungs. In: Hickey AJ, editor. Inhalation aerosols: physical and biological basis for therapy. Lung Biology in Health and Disease, vol 94 New York: Marcel Dekken; 1996;441-473
51. Clark T, Rees J. Practical management of asthma. London: Martin Dunitz; 1985:134.
52. Crompton GK Delivery systems. In: Kay AB, editor. Allergy and allergic diseases, London. Blackwell Science; 1997:1440-1450.